Trans India House Impex Ltd: ₹60 Cr Sales, 818 Debtor Days & Rights Issue Dhamaka

1. At a Glance

From being a dead shell called IO System Ltd till FY22 (zero business, just interest income) to suddenly becoming an “export trading” hero with ₹60 Cr sales in FY25, Trans India House Impex is basically a Bollywood-style comeback story. Except… the hero is still late on payments (debtors = 818 days, i.e., “pay after 2 years, bro”), promoters cut stake from 74% to 27%, and P/E sits at 123x. Stock trades at ₹16.7, but the balance sheet drama makes it look like a ₹2 chai shop trying to open outlets in Dubai and West Africa.

2. Introduction

Picture this: a 1987-incorporated company that was lying flat, renamed in 2022, then pumped with reclassified shares, rights issues, and new promoters. Now they’re trading tiles, food, and textiles like it’s a general store for exporters.

But behind the fancy press releases about new Dubai subsidiaries and Senegal stores, the reality is:

OPM = 3.6% (on ₹60 Cr sales, just ₹2.2 Cr operating profit).
Net profit = < ₹1 Cr.
Debt = ₹33 Cr, i.e., 34x profit.
Promoters are running towards the exit — stake down to 27.7% by June 2025.

So, is this company rising phoenix or just rights-issue ka circus?

3. Business Model (WTF Do They Even Do?)

On paper, it’s a full-service import-export + logistics + merchant trading firm. Reality check:

Import-Export Services → End-to-end solutions. Translation: “We’ll file documents and arrange containers.”
Logistics → Cargo clearance, warehousing, terminals. Basically, freight forwarding middleman.
Merchant Trading → Sourcing and re-selling commodities. A desi “Alibaba B2B” wannabe.
Products → From ceramic tiles to dehydrated onions to packaging. Feels less like focused strategy, more like “jo mil jaaye, bech do.”

Verdict: A jack-of-all-trades exporter, but thin margins show it’s more a volume game than brand-building.

4. Financials Overview (Q1 FY26)

Source table

Metric	Jun’25	Jun’24	Mar’25	YoY %	QoQ %
Revenue	₹23.6 Cr	₹6.0 Cr	₹10.5 Cr	291%	125%
EBITDA	₹0.67 Cr	₹0.44 Cr	₹0.56 Cr	52%	20%
PAT	₹0.18 Cr	₹0.24 Cr	₹0.27 Cr	-25%	-33%
EPS	₹0.03	₹0.03	₹0.04	Flat	Down

Commentary: Sales are growing, but profits are shrinking. Why? Margins are thinner than tissue paper.

5. Valuation (Fair Value RANGE)

P/E Method: EPS ₹0.14 × industry P/E 37 → FV ≈ ₹5.
EV/EBITDA: EV ₹149 Cr / EBITDA ~₹4 Cr = 36x. Industry ~12x → FV ≈ ₹10–₹12.
DCF (optimistic): Assume PAT ₹5 Cr in 3 years, discount at 12% → FV ≈ ₹20.

Fair Value Range: ₹5 – ₹20.
“This FV range is for educational purposes only and is not investment advice.”

6. What’s Cooking – News, Triggers, Drama

Rights Issue (2025): ₹49.38 Cr raised at ₹13.90/share. Capital doubled overnight. Public dilution alert.
Global Expansion: New subsidiary in Dubai + retail stores in Senegal. Sounds sexy, but remember — earlier they couldn’t even do business in UP.
Management Shuffle: CFO resigns every year like it’s a relay race.

To Read Full 16 Point